PPMS- UK Overview
US$ 3,000.00
... . The report gives the overview of Primary Progressive multiple sclerosis disease indication in detail in UK market, highlights the PPMS epidemiology in UK, elaborates on ... forms of MS. The final part of the report gives a detailed overview of PPMS market sizing drug wise in UK both in terms of value sales ...
September 2017
73 pages
PPMS- US Overview
US$ 3,000.00
... The report gives the overview of Primary Progressive multiple sclerosis disease indication in detail in the US market, highlights the PPMS epidemiology in the US, ... progressive forms of MS. The final part of the report gives a detailed overview of PPMS market sizing drug wise in the US both in terms of value ...
September 2017
73 pages
SPMS- France Overview
US$ 3,000.00
... report gives the overview of Secondary progressive multiple sclerosis disease indication in detail in France market, highlights the SPMS epidemiology in France, elaborates on ... final part of the report gives a detailed overview of SPMS market sizing drug wise in France both in terms of value sales and patient ...
September 2017
78 pages
SPMS- Germany Overview
US$ 3,000.00
... gives the overview of Secondary progressive multiple sclerosis disease indication in detail in Germany market, highlights the SPMS epidemiology in Germany, elaborates on ... final part of the report gives a detailed overview of SPMS market sizing drug wise in Germany both in terms of value sales and patient ...
September 2017
78 pages
SPMS- Italy Overview
US$ 3,000.00
... report gives the overview of Secondary progressive multiple sclerosis disease indication in detail in Italy market, highlights the SPMS epidemiology in Italy, elaborates on ... The final part of the report gives a detailed overview of SPMS market sizing drug wise in Italy both in terms of value sales and patient ...
September 2017
78 pages
SPMS- Spain Overview
US$ 3,000.00
... report gives the overview of Secondary progressive multiple sclerosis disease indication in detail in Spain market, highlights the SPMS epidemiology in Spain, elaborates on ... The final part of the report gives a detailed overview of SPMS market sizing drug wise in Spain both in terms of value sales and patient ...
September 2017
78 pages
SPMS- UK Overview
US$ 3,000.00
... . The report gives the overview of Secondary progressive multiple sclerosis disease indication in detail in UK market, highlights the SPMS epidemiology in UK, elaborates on ... forms of MS. The final part of the report gives a detailed overview of SPMS market sizing drug wise in UK both in terms of value sales ...
September 2017
78 pages
SPMS- US Overview
US$ 3,000.00
... The report gives the overview of Secondary progressive multiple sclerosis disease indication in detail in the US market, highlights the SPMS epidemiology in the US, ... progressive forms of MS. The final part of the report gives a detailed overview of SPMS market sizing drug wise in the US both in terms of value ...
September 2017
78 pages
Major Depressive Disorder (Mdd) - Market Outlook, Market Forecast And Competitve Landscape Report - 20185 To 2030
US$ 5,000.00
Thelansis Knowledge Partners 'Major Depressive Disorder (MDD)' - Market Outlook, Market Forecast ... , Prevalence and mortality) and forecasted trend for 8 major markets (US, Germany, France, Italy, Spain, UK, ... Phase I, Phase II and Phase III including their major milestones, study result, interim result, safety & ...
September 2017
257 pages
Human Papillomavirus (Hpv) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Human Papillomavirus (HPV)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...
September 2017
216 pages
Uveitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Uveitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
September 2017
204 pages
Cutaneous T-Cell Lymphoma(Ctcl) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Cutaneous T-Cell Lymphoma(CTCL)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...
September 2017
195 pages
Interstitial Cystitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Interstitial Cystitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
September 2017
208 pages
H3N2 Infection - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'H3N2 Infection' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
September 2017
147 pages
Helicobacter Pylori Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Helicobacter Pylori Infections' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...
September 2017
217 pages
Hemophilia B - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hemophilia B' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
September 2017
158 pages
Hepatic Encephalopathy - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hepatic Encephalopathy' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
September 2017
190 pages
Hepatitis A - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hepatitis A' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
September 2017
199 pages
Herpes Labialis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Herpes Labialis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
September 2017
158 pages
Hot Flashes - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hot Flashes' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
September 2017
157 pages
Hyperkalemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hyperkalemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
September 2017
184 pages
Hyperparathyroidism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hyperparathyroidism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
September 2017
200 pages
Hyperphosphatemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hyperphosphatemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
September 2017
158 pages
Hypertriglyceridemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hypertriglyceridemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
September 2017
196 pages
Hyperuricemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Hyperuricemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
September 2017
208 pages
Herpetic Keratitis (Hk) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Herpetic Keratitis(HK)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...
September 2017
165 pages
China Medical Electrodes Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
US$ 4,480.00
... display the China Medical Electrodes market. Chapter 1, to describe Medical Electrodes Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter ...
September 2017
117 pages
China Scar Dressing Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
US$ 4,480.00
... display the China Scar Dressing market. Chapter 1, to describe Scar Dressing Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter ...
September 2017
123 pages
China Tissue Engineering Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
US$ 4,480.00
... display the China Tissue Engineering market. Chapter 1, to describe Tissue Engineering Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter ...
September 2017
119 pages
Global Dry Mouth Relief Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 3,480.00
... display the global Dry Mouth Relief market. Chapter 1, to describe Dry Mouth Relief Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Dry Mouth Relief, with ...
September 2017
116 pages
Global Capecitabine Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 3,480.00
... display the global Capecitabine market. Chapter 1, to describe Capecitabine Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Capecitabine, with sales ...
September 2017
121 pages
Global Amebocyte Lysate Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 3,480.00
... are 15 Chapters to deeply display the global Amebocyte Lysate market. Chapter 1, to describe Amebocyte Lysate Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...
September 2017
115 pages
Asia-Pacific Antibody Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
... the Asia-Pacific Antibody market. Chapter 1, to describe Antibody Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Antibody ...
September 2017
115 pages
Asia-Pacific Dental Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
... Asia-Pacific Dental Drug market. Chapter 1, to describe Dental Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Dental Drug ...
September 2017
121 pages
Asia-Pacific Probiotics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
... the Asia-Pacific Probiotics market. Chapter 1, to describe Probiotics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Probiotics ...
September 2017
117 pages
EMEA Fetal Bovine Serum Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
... focuses on the Fetal Bovine Serum in EMEA market, covering Europe, ... EMEA Fetal Bovine Serum market. Chapter 1, to describe Fetal Bovine Serum Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Fetal Bovine Serum ...
September 2017
117 pages
